Business Context and Reporting Period
This Form 8-K filing by AmerisourceBergen Corporation (now Cencora, Inc.) is dated May 15, 2014. The report details the election of a new director to the Board of Directors and the expansion of the Board size from ten to eleven members. The filing is driven by a strategic relationship and Shareholders Agreement between AmerisourceBergen, Walgreen Co. (Walgreens), and Alliance Boots.
Key Financial Metrics
The filing does not provide specific financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. The document focuses exclusively on corporate governance changes and the terms of the strategic partnership.
Material Changes
- Board Expansion: The Board of Directors was expanded from ten to eleven directors.
- Director Election: Gregory D. Wasson, President and CEO of Walgreens, was elected to the Board for a term ending in March 2015.
- Ownership Threshold: As of April 9, 2014, Walgreens and Alliance Boots (the "Investors") collectively owned approximately 5% of the Company's common stock, triggering the right to designate one director.
Outlook, Risks, and Contingencies
Strategic Relationship: The Company has a multi-billion dollar primary pharmaceutical distribution agreement with Walgreens, expected to be fully implemented by the end of fiscal 2014. This includes access to generic drugs through a joint venture.
Equity Rights and Governance:
- Warrants: Walgreens and Alliance Boots hold warrants to purchase up to 22,696,912 shares each (Warrant 1 at $51.50; Warrant 2 at $52.50), exercisable starting March 2016 and March 2017, respectively.
- Open Market Shares: The Investors have rights to purchase up to 19,859,795 shares in open market transactions.
- Future Board Representation: Upon full exercise of Warrant 1 and acquisition of Initial Open Market Shares, Walgreens will be entitled to designate a second director.
- Divestiture Risks: If Investors divest to less than 14% but at least 5%, Walgreens retains one director seat. If ownership falls below 5%, Walgreens loses all board designation rights.
Compensation: Mr. Wasson has waived any compensation for his service as a director.
Investor Verification Checklist
- Verify the current ownership percentage of Walgreens and Alliance Boots to confirm ongoing board representation rights.
- Review the progress of the multi-billion dollar distribution agreement implementation status for fiscal 2014.
- Monitor the exercise dates and conditions for Warrant 1 (March 2016) and Warrant 2 (March 2017).
- Confirm the terms of the Shareholders Agreement regarding transfer restrictions and voting arrangements.